Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae
- PMID: 16940068
- PMCID: PMC1635225
- DOI: 10.1128/AAC.00626-06
Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae
Abstract
The molecular mechanisms of reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae, particularly amino acid substitutions in mosaic penicillin-binding protein 2 (PBP2), were examined. The complete sequence of ponA, penA, and por genes, encoding, respectively, PBP1, PBP2, and porin, were determined for 58 strains isolated in 2002 from Japan. Replacement of leucine 421 by proline in PBP1 and the mosaic-like structure of PBP2 were detected in 48 strains (82.8%) and 28 strains (48.3%), respectively. The presence of mosaic PBP2 was the main cause of the elevated cefixime MIC (4- to 64-fold). In order to identify the mutations responsible for the reduced susceptibility to cefixime in isolates with mosaic PBP2, penA genes with various mutations were transferred to a susceptible strain by genetic transformation. The susceptibility of partial recombinants and site-directed mutants revealed that the replacement of glycine 545 by serine (G545S) was the primary mutation, which led to a two- to fourfold increase in resistance to cephems. Replacement of isoleucine 312 by methionine (I312M) and valine 316 by threonine (V316T), in the presence of the G545S mutation, reduced susceptibility to cefixime, ceftibuten, and cefpodoxime by an additional fourfold. Therefore, three mutations (G545S, I312M, and V316T) in mosaic PBP2 were identified as the amino acid substitutions responsible for reduced susceptibility to cefixime in N. gonorrhoeae.
Figures


Similar articles
-
Cefpodoxime 10 μg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes.APMIS. 2011 Jun;119(6):356-63. doi: 10.1111/j.1600-0463.2011.02729.x. Epub 2011 Feb 24. APMIS. 2011. PMID: 21569093
-
Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.J Antimicrob Chemother. 2014 Jun;69(6):1510-6. doi: 10.1093/jac/dkt543. Epub 2014 Feb 13. J Antimicrob Chemother. 2014. PMID: 24532681
-
Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2.J Antimicrob Chemother. 2010 Aug;65(8):1615-8. doi: 10.1093/jac/dkq187. Epub 2010 May 28. J Antimicrob Chemother. 2010. PMID: 20511367
-
Emergence and spread of drug resistant Neisseria gonorrhoeae.J Urol. 2010 Sep;184(3):851-8; quiz 1235. doi: 10.1016/j.juro.2010.04.078. J Urol. 2010. PMID: 20643433 Review.
-
Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins.Curr Opin Infect Dis. 2009 Feb;22(1):87-91. doi: 10.1097/QCO.0b013e328320a836. Curr Opin Infect Dis. 2009. PMID: 19532086 Review.
Cited by
-
Characterizing the diversity and commensal origins of penA mosaicism in the genus Neisseria.Microb Genom. 2024 Feb;10(2):001209. doi: 10.1099/mgen.0.001209. Microb Genom. 2024. PMID: 38381035 Free PMC article.
-
Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou, China (2009-2013): coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics.BMC Infect Dis. 2016 Apr 14;16:152. doi: 10.1186/s12879-016-1469-3. BMC Infect Dis. 2016. PMID: 27080231 Free PMC article.
-
Molecular Mechanisms of Drug Resistance and Epidemiology of Multidrug-Resistant Variants of Neisseria gonorrhoeae.Int J Mol Sci. 2022 Sep 10;23(18):10499. doi: 10.3390/ijms231810499. Int J Mol Sci. 2022. PMID: 36142410 Free PMC article. Review.
-
Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.Future Microbiol. 2012 Dec;7(12):1401-22. doi: 10.2217/fmb.12.117. Future Microbiol. 2012. PMID: 23231489 Free PMC article. Review.
-
Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection.Antimicrob Agents Chemother. 2008 Oct;52(10):3564-7. doi: 10.1128/AAC.00198-08. Epub 2008 Jul 28. Antimicrob Agents Chemother. 2008. PMID: 18663018 Free PMC article.
References
-
- Akasaka, S., T. Muratani, Y. Yamada, H. Inatomi, K. Takahashi, and T. Matsumoto. 2001. Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce β-lactamase. J. Infect. Chemother. 7:49-50. - PubMed
-
- Ameyama, S., S. Onodera, M. Takahata, S. Minami, N. Maki, K. Endo, H. Goto, H. Suzuki, and Y. Oishi. 2002. Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob. Agents Chemother. 46:3744-3749. - PMC - PubMed
-
- Bowler, L. D., Q. Y. Zhang, J. Y. Riou, and B. G. Spratt. 1994. Interspecies recombination between the penA genes of Neisseria meningitidis and commensal Neisseria species during the emergence of penicillin resistance in N. meningitidis: natural events and laboratory simulation. J. Bacteriol. 176:333-337. - PMC - PubMed
-
- Brannigan, J. A., I. A. Tirodimos, Q. Y. Zhang, C. G. Dowson, and B. G. Spratt. 1990. Insertion of an extra amino acid is the main cause of the low affinity of penicillin-binding protein 2 in penicillin-resistant strains of Neisseria gonorrhoeae. Mol. Microbiol. 4:913-919. - PubMed
-
- Deguchi, T., M. Yasuda, S. Yokoi, K. Ishida, M. Ito, S. Ishihara, K. Minamidate, Y. Harada, K. Tei, K. Kojima, M. Tamaki, and S. Maeda. 2003. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. J. Infect. Chemother. 9:35-39. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases